CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

AstraZeneca Pharma India Ltd.

NSE : ASTRAZENEQ BSE : 506820 ISIN CODE : INE203A01020Industry : Pharmaceuticals

News

  • AstraZeneca Pharma I - General Updates 20 Mar 2026 | 12:10 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Announcement under Regulation 30 (LODR)-Resignation of Director 20 Mar 2026 | 12:08 | Dion Global

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.more...

  • AstraZeneca Pharma I - General Updates 17 Mar 2026 | 15:07 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 17 Mar 2026 | 15:05 | Dion Global

    Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.more...

  • AstraZeneca Pharma I - Trading Window 13 Mar 2026 | 17:02 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Reg...more...

  • AstraZeneca Pharma I - General Updates 11 Mar 2026 | 16:39 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Shareholders meeting 27 Feb 2026 | 16:56 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange regarding Notice of Postal Ballotmore...

  • AstraZeneca Pharma I - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 27 Feb 2026 | 16:41 | Dion Global

    Please find the enclosed Postal Ballot Notice dated February 11 2026 for your reference.more...

  • AstraZeneca Pharma I - Copy of Newspaper Publication 19 Feb 2026 | 18:22 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • AstraZeneca Pharma I - Certificate under SEBI (Depositories and Participants) Regulations, 2018 19 Feb 2026 | 18:04 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...

  • AstraZeneca Pharma I - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 19 Feb 2026 | 18:02 | Dion Global

    Please find the enclosed certificate of the Company in relation to the captioned subject for your reference.more...

  • AstraZeneca Pharma I - General Updates 18 Feb 2026 | 15:33 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I Q3 net profit up 5.64% at Rs 32.59 cr 11 Feb 2026 | 19:30 | Dion Global

    The company reported standalone net profit of Rs 32.59 crore for the quarter ended December 31 2025 as compared to Rs 30.85 crore in the same period ...more...

  • AstraZeneca Pharma I - Outcome of Board Meeting 11 Feb 2026 | 19:05 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11 2026.more...

  • AstraZeneca Pharma I - Outcome Of The Board Meeting Held On Wednesday, February 11, 2026 11 Feb 2026 | 19:00 | Dion Global

    Please find the enclosed financials of the Company for the quarter ended December 31 2025 for your reference.more...

  • AstraZeneca Pharma I - General Updates 11 Feb 2026 | 17:51 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Appointment of Company Secretary and Compliance Officer 11 Feb 2026 | 17:45 | Dion Global

    Please find the enclosed letter of the Company as per the captioned subject for your reference.more...

  • AstraZeneca gets CDSCO approval for Imfinzi in additional cancer indication 10 Feb 2026 | 14:35 | Dion Global

    AstraZeneca Pharma India Ltd on Tuesday said it has received regulatory approval from India s drug regulator to market its cancer therapy Im...more...

  • AstraZeneca Pharma I - General Updates 10 Feb 2026 | 10:57 | Dion Global

    AstraZeneca Pharma India Limited has informed the Exchange about General Updatesmore...

  • AstraZeneca Pharma I - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2 10 Feb 2026 | 10:53 | Dion Global

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.more...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex75273.451.63%
B500DIVL503393.431.18%
BSE 1000 9971.851.93%
BSE 100LCTMC8639.481.75%
BSE Auto 55417.252.25%
BSE BasicMat7655.132.75%

Commodity

Gold1447833.19%
Silver2342204.35%
Copper1159.15184.24%
Crude Oil867035.19%
Lead196.6546.32%
Mentha Oil1091.12.22%
Nickel1626.8112.13%

Currency

USD/INR 93.88(-0.01 %)
GBP/INR 125.83(0.81 %)
EUR/INR 108.74(0.47 %)
JPY/INR 0.59(0.28 %)
CAD/INR 68.24(0.36 %)
HKD/INR 11.99(0.64 %)